CN Patent

CN103608346B — 作为缺氧诱导因子(hif)羟化酶抑制剂的萘啶衍生物

Assigned to Fibrogen China Medical Technology Development Co Ltd · Expires 2016-06-15 · 10y expired

What this patent protects

本发明涉及能够抑制HIF羟化酶活性、从而提高缺氧诱导因子(HIF)稳定性和/或活性的新化合物、方法和组合物，

USPTO Abstract

本发明涉及能够抑制HIF羟化酶活性、从而提高缺氧诱导因子(HIF)稳定性和/或活性的新化合物、方法和组合物，

Drugs covered by this patent

Patent Metadata

Patent number
CN103608346B
Jurisdiction
CN
Classification
—
Expires
2016-06-15
Drug substance claim
No
Drug product claim
No
Assignee
Fibrogen China Medical Technology Development Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.